Mayer Eldon C. III 4
4 · Eiger BioPharmaceuticals, Inc. · Filed Jan 30, 2023
Insider Transaction Report
Form 4
Mayer Eldon C. III
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-01-26+31,500→ 31,500 totalExercise: $1.37Exp: 2033-01-26→ Common Stock (31,500 underlying)
Footnotes (1)
- [F1]The option vests as to 50% on the first anniversary of the January 26, 2023 grant date, and as to the remaining 50% on June 26, 2024, subject to the Reporting Person's continuous service as of each such date. The option vests in full upon a change in control of the Issuer.